Work

Abstract PS4-11-12: Impact of the ESMO-MCBS v2.0 on Benefit-Risk Assessment of Emerging Therapies in Early Breast Cancer: A Comparison with the ASCO Value Framework

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-11-12

Authors: A. Longobardi, V. Molinaro, V. Cantile, R. Buonaiuto, A. Caltavituro, G. Crimaldi, M. Giuliano, G. Arpino, C. De Angelis

Institutions: Federico II University Hospital, University of Naples Federico II, Ospedale Policlinico San Martino, Scuola Superiore Meridionale

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130161874

Cites:

Cited by:

Related to: